| Schedule of segment information |
| Schedule of segment information | |
| | | |
| | |
| | |
Year Ended June 30, | |
| | |
2026 | | |
2025 | |
| Revenue | |
$ | 3,000 | | |
$ | 203,000 | |
| Cost of revenue | |
| – | | |
| (38,000 | ) |
| Gross profit | |
| 3,000 | | |
| 165,000 | |
| | |
| | | |
| | |
| Research and development | |
| (11,000 | ) | |
| (95,000 | ) |
| Salaries | |
| (493,000 | ) | |
| (471,000 | ) |
| Consulting fees | |
| (101,000 | ) | |
| (67,000 | ) |
| Professional fees | |
| (171,000 | ) | |
| (168,000 | ) |
| Rent expense | |
| (36,000 | ) | |
| (29,000 | ) |
| Travel expense | |
| (56,000 | ) | |
| (30,000 | ) |
| Stock-based compensation | |
| (394,000 | ) | |
| (201,000 | ) |
| Other operating expenses | |
| (129,000 | ) | |
| (91,000 | ) |
| Total operating expenses | |
| (1,391,000 | ) | |
| (1,152,000 | ) |
| | |
| | | |
| | |
| Net operating loss | |
| (1,388,000 | ) | |
| (987,000 | ) |
| | |
| | | |
| | |
| Gain on patent assignment | |
| – | | |
| 880,000 | |
| Interest and other expense, net | |
| (40,000 | ) | |
| (6,000 | ) |
| Change in fair value of derivative liability | |
| 24,000 | | |
| – | |
| Net loss | |
$ | (1,404,000 | ) | |
$ | (113,000 | ) |
|